Further to the request for Voluntary Suspension on 24 October 2018, ResApp Health Limited (ASX:RAP) (“Company” advises that it has received the US SMARTCOUGH-C-2 study results and is currently in the process of analysing these results. The Company anticipates that it will be in a position to release a full update to the market on Tuesday 30 October 2018.
Calm the farm people.....
Ann: Voluntary Suspension Update, page-23
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #